Can Hydroxychloroquine Cause G6PD-Related Hemolysis? A Case Study
Dubai Medical Journal · 17.11.2020 · 3 (4) · 140-142
DOI: 10.1159/000511688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dubai Medical Journal, online erschienen am 17.11.2020. Verfasst von Khaldun Obeidat und 1 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
During the pandemic of COVID-19, which started in December 2019, hydroxychloroquine, the drug which was first introduced as antimalarial medication, was widely used to treat this new viral infection, and it was reported in the literature as a safe drug for use in patients with G6PD deficiency; here, we report a 64-year-old male who was started on hydroxychloroquine as treatment for COVID-19 that led to hemolysis, and further investigation showed that the patient is deficient for glucose-6-phosphate dehydrogenase.
Zitieren
APA
Obeidat, K., & Yassin, M. A. (2020). Can Hydroxychloroquine Cause G6PD-Related Hemolysis? A Case Study. Dubai Medical Journal, 3(4), 140-142. https://doi.org/10.1159/000511688
Vancouver
Obeidat K, Yassin MA. Can Hydroxychloroquine Cause G6PD-Related Hemolysis? A Case Study. Dubai Medical Journal. 2020;3(4):140-142. doi:10.1159/000511688
BibTeX
@article{Obeidat2020,
author = {Obeidat, Khaldun and Yassin, Mohamed A.},
title = {Can Hydroxychloroquine Cause G6PD-Related Hemolysis? A Case Study},
journal = {Dubai Medical Journal},
year = {2020},
volume = {3},
number = {4},
pages = {140--142},
doi = {10.1159/000511688}
}
EUVIMED